Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.
Stephanie M YoonElaine LutersteinFang-I ChuMinsong CaoJames LambNzhde AgazaryanDaniel LowAnn C RaldowMichael L SteinbergPercy LeePublished in: Cancer medicine (2021)
Favorable LC and PFS outcomes were observed with minimal morbidity for tumors in the abdomen and pelvis treated with SMART. Future prospective clinical trials to validate these findings are warranted.
Keyphrases
- magnetic resonance
- clinical trial
- early stage
- squamous cell carcinoma
- small cell lung cancer
- locally advanced
- radiation therapy
- contrast enhanced
- simultaneous determination
- randomized controlled trial
- magnetic resonance imaging
- mass spectrometry
- type diabetes
- phase ii
- skeletal muscle
- insulin resistance
- double blind
- rectal cancer
- glycemic control
- solid phase extraction